Date published: 2025-11-24

00800 4573 8000

SCBT Portrait Logo
Seach Input

Inhibiteurs DEAH-box RNA-dependent NTPase (DHX)

The DEAH-box family of RNA-dependent NTPases (DHX) plays a crucial role in RNA metabolism, including processes such as splicing, ribosome biogenesis, and mRNA export from the nucleus. These proteins act as molecular motors that harness the energy from nucleotide hydrolysis to unwind or remodel RNA and RNA-protein complexes. The DHX proteins generally contain conserved motifs that are essential for ATP binding and hydrolysis, as well as RNA binding and unwinding. Through their ATPase and helicase activities, DHX proteins are able to dynamically regulate the structure and function of various RNA molecules and complexes, thereby influencing diverse cellular processes.

The class of molecules known as DEAH-box RNA-dependent NTPase (DHX) Inhibitors is specifically designed to modulate the activity of the DHX family of proteins, which are central to RNA metabolism in the cell. These inhibitors typically target the ATPase or helicase domains of DHX proteins, as these are the functional cores responsible for nucleotide binding, hydrolysis, and the subsequent RNA remodeling activities. Some inhibitors may act by binding directly to the ATPase pocket, thereby ATP from binding and disabling the enzyme's activity. Others may bind to regions of the protein that are essential for RNA interaction, therefore making the protein unable to engage with its natural RNA substrates. Some inhibitors are allosteric in nature and can bind to regions other than the active site, causing conformational changes that make the enzyme less effective or completely inactive.

VOIR ÉGALEMENT...

Items  1  to  10  of  11 total

Afficher:

Nom du produitCAS #Ref. CatalogueQuantitéPrix HTCITATIONS Classement

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Inhibiteur de PI3K affectant les voies de traitement de l'ARN en aval.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Inhibe la synthèse des protéines et affecte indirectement le traitement de l'ARN.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

Inhibe JNK, qui joue un rôle dans l'épissage de l'ARN.

Akt Inhibitor IV

681281-88-9sc-203809
sc-203809A
5 mg
25 mg
$173.00
$695.00
42
(1)

Inhibe Akt, qui est impliqué dans le traitement de l'ARN.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibiteur de la JNK pouvant affecter l'épissage de l'ARN.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$76.00
$216.00
101
(4)

Influence la fonction des hélicases à ARN comme DDX38 en causant des dommages à l'ADN.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$36.00
$149.00
11
(1)

Intervient indirectement dans l'activité de l'ARN hélicase en perturbant le métabolisme des nucléotides.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Inhibiteur de la topoisomérase II affectant potentiellement le traitement de l'ARN.

2′-Deoxy-2′,2′-difluorocytidine

95058-81-4sc-275523
sc-275523A
1 g
5 g
$56.00
$128.00
(1)

Intervient dans la synthèse et la réparation de l'ADN, en affectant les hélicases de l'ARN comme DDX38.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

Inhibiteur de la topoisomérase I qui cause des dommages à l'ADN en affectant les hélicases ARN comme DDX38.